Non-Hodgkin lymphoma is a diverse set of cancers arising from lymphocytes. Common signs include painless swollen lymph nodes and B symptoms (fever, night sweats, weight loss). Definitive diagnosis requires a biopsy; CT and PET-CT help stage disease. Treatment is subtype- and stage-specific and ranges from watchful waiting to chemotherapy with targeted agents, radiation, or transplant. Prognosis depends on subtype, stage, and patient factors.

What is Non-Hodgkin Lymphoma?

Non-Hodgkin lymphoma (NHL) is a group of cancers that begin in the lymphatic system, which includes lymph nodes, spleen, bone marrow, and other tissues. Lymphocytes - immune cells that fight infection - stop functioning normally when they become cancerous. NHL contains many distinct subtypes; most are B-cell lymphomas, while a smaller portion arise from T-cells.

How it can present

People often notice a painless swollen lymph node in the neck, armpit, or groin. Other common signs include fever, night sweats, unexplained weight loss and persistent fatigue - these are sometimes called "B symptoms." Some patients have itching (pruritus) or symptoms related to a mass pressing on nearby organs. In early stages some individuals have no symptoms at all.

How doctors diagnose NHL

Diagnosis relies on a combination of history, physical exam and tests. The definitive test is a tissue biopsy, usually an excisional lymph node biopsy or core needle biopsy, examined by a pathologist. Blood tests provide supportive information. Imaging - commonly CT and PET-CT scans - helps define the extent of disease and guide staging. Bone marrow biopsy may be done in certain subtypes.

Staging and prognosis

Physicians commonly use the Ann Arbor staging system to describe how far lymphoma has spread (stages I-IV). Prognosis depends heavily on the lymphoma subtype, stage, patient age and overall health. For aggressive lymphomas clinicians often use scoring tools such as the International Prognostic Index (IPI) to estimate risk and guide treatment.

Treatment options

Treatment varies by subtype and stage. Options include:

  • Observation ("watchful waiting") for some slow-growing lymphomas
  • Radiation therapy for localized disease
  • Chemotherapy regimens, often combined with immunotherapy
  • Monoclonal antibodies and targeted agents (for example, anti-CD20 therapies for many B-cell lymphomas)
  • Stem cell transplant in relapsed or high-risk cases
Your hematologist/oncologist will recommend a plan tailored to your subtype, stage and overall health.

Living with and after treatment

Follow-up includes periodic physical exams, blood work and imaging to monitor for recurrence and treatment effects. Supportive care (infection prevention, managing side effects, and addressing emotional needs) is an important part of care. Many people live long, productive lives after successful treatment; outcomes vary by subtype and stage.

When to see a doctor

See your primary care doctor if you have a persistent, painless swollen lymph node, unexplained fever, night sweats, or weight loss. Early evaluation helps identify treatable causes and, if needed, get you to a specialist quickly.

FAQs about Non Hodgkins Lymphoma

What is the most important test to diagnose Non-Hodgkin lymphoma?
A tissue biopsy (excisional or core needle) examined by a pathologist is required to confirm Non-Hodgkin lymphoma and determine the subtype.
Can Non-Hodgkin lymphoma be cured?
Some types of NHL can be cured, especially aggressive subtypes treated early; others are managed as chronic conditions. Prognosis depends on subtype, stage, and individual health.
What are common symptoms of NHL?
Common symptoms include a painless swollen lymph node, unexplained fever, night sweats, weight loss, fatigue, and sometimes itching.
How is NHL staged?
Clinicians use the Ann Arbor system (stages I-IV) to describe spread. Imaging like CT and PET-CT, and sometimes bone marrow biopsy, help determine the stage.
Who treats Non-Hodgkin lymphoma?
Hematologists or medical oncologists who specialize in blood cancers typically manage NHL, often working with radiation oncologists and transplant teams when needed.